Pharma Sector Report
I used Power BI to analyze the digital performance and positioning of a pharmaceutical company working in drug repurposing. The goal was to understand how the company is showing up online, how potential customers and investors are engaging with it, and how its digital footprint compares to its competitors. The dashboard includes metrics on traffic trends, bounce rate, site engagement, keyword visibility, and mentions across news and social media.
(Summary of insights below visualization)
Key Insights
The report shows that the company’s website traffic has dropped sharply since early 2022, with a 93 percent decrease in visits and an 80 percent drop in unique visitors. Most users are spending less than 20 seconds on the site before leaving, which, combined with a bounce rate above 60 percent, points to low engagement and unclear value for potential customers or investors.
Several issues stand out. The site has broken links, low authority due to weak backlink profiles, and no clear call to action. Traffic patterns are inconsistent month to month, and the company’s visibility in organic search is limited. Keyword strength is low, and the company’s name shows up in search results primarily through one news outlet and its own social media, with little external conversation happening.
Compared to competitors, the company falls behind in nearly every metric, especially in digital reach and content strategy. Its rivals are attracting more traffic through stronger SEO, clearer messaging, and more robust social media presence. The company’s own channels are underutilized, but there is room to grow if efforts are aligned around consistent content, stronger search optimization, and better audience targeting.
Altogether, these trends point to a need for strategic digital improvements. Strengthening organic traffic, fixing technical issues, and expanding third-party engagement can help the company better support its upcoming press release and future initiatives in the drug repurposing space.